Effects of liraglutide on hemodynamic parameters in patients with heart failure
Authors:
Open Access
- 19 June 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (37) , 62693-62702
Abstract
Effects of liraglutide on hemodynamic parameters in patients with heart failure Effects of liraglutide on hemodynamic parameters in patients with heart failureKeywords
This publication has 37 references indexed in Scilit:
- Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the ratCardiovascular Diabetology, 2013
- [Exenatide stimulated solute-free water excretion by human kidney].2012
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentEuropean Heart Journal, 2010
- Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in MiceDiabetes, 2009
- Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone RatCirculation: Heart Failure, 2008
- Estrés oxidativo e inflamación en insuficiencia cardiaca: Mecanismos de daño y alternativas terapéuticasRevista médica de Chile, 2007
- Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in HumansDigestion, 2006
- Global End-Diastolic Volume as an Indicator of Cardiac Preload in Patients With Septic Shock *Chest, 2003
- Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acidAnalytical Biochemistry, 1992